Patients with polycystic ovary syndrome with persistent anovulation or sporadic ovulation, if there is a requirement for fertility, clomiphene citrate, letrozole, gonadotropins and other drugs can be applied to promote ovulation, no matter the fastest ovulation-promoting drugs.
1. Clomiphene citrate: the first-line drug to promote ovulation in patients with polycystic ovaries, starting from the 2nd to 5th day of menstruation or withdrawal bleeding, taking 5 days, if there is still no ovulation, long follicular phase, short luteal phase and other conditions, the drug dose can be adjusted under the guidance of the doctor, and the drug alone is generally not more than 6 cycles.
2. Letrozole: It is also the first-line drug for promoting ovulation in patients with polycystic ovaries, and can also be used in patients with resistance to clomiphene citrate or failure of ovulation promotion, starting from menstruation or natural withdrawal of bleeding on the 2nd~5th day of the drug, and used for 5 days in a row, and if there is no ovulation, adjust the dosage of the drug under the guidance of a doctor.
3. Gonadotropins: human menopausal gonadotropins, high-purity follicle-stimulating hormone, genetically recombinant follicle-stimulating hormone, can be used as a second-line treatment option in conjunction with clomiphene citrate and letrozole.
For the preparation of polycystic ovary patients, it is first recommended that both husband and wife undergo a comprehensive examination in the hospital to remove the risk factors that cause pregnancy failure, if the control is still ineffective, can be under the guidance of the doctor medication to promote ovulation.